Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JZ5Y
|
|||
| Former ID |
DIB015297
|
|||
| Drug Name |
Gp75 DNA vaccine
|
|||
| Synonyms |
Gp75 DNA vaccine (melanoma); Cancer vaccine, Memorial Sloan-Kettering/Powderject; Gp75 DNA vaccine (melanoma), Memorial Sloan-Kettering Cancer Center; Melanoma vaccine, Memorial Sloan-Kettering/PowderJect; Melanoma vaccine, PowderJect/Memorial Sloan-Kettering
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Memorial Sloan-Kettering Cancer Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00034554) Study of gp75 Vaccine in Patients With Stage III and IV Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.